management of relapsed dlbcl in era of car t therapy
Published 5 years ago • 642 plays • Length 51:15Download video MP4
Download video MP3
Similar videos
-
54:11
car t-cells in lymphoma: new advances and practical aspects
-
55:58
role of cd19 car t cells in second line large b cell lymphoma
-
30:02
car-t cell therapy in lymphoma
-
39:11
car-t cell therapy for adult all
-
48:12
outcomes of patients with aggressive b-cell lymphoma after failure of anti-cd19 car t-cell therapy
-
52:11
car-t cells in lymphoma: the latest data
-
26:53
ictc: session 1 - therapeutic landscape in the treatment of relapsed b cell lympoma
-
28:15
management of t-all: an update
-
53:15
cd19 car t cells in lymphoid malignancies – 2018 update
-
40:20
high-risk mds follonig car t cells in patients with rr dlbcl
-
18:12
2022 west oncology conference | treatment sequencing in relapsed/refractory dlbcl in era of car-t
-
54:02
management of high-risk chronic lymphocytic leukemia
-
4:05
car-t therapy for r/r aggressive b-cell nhl
-
6:54
the future of car-t therapy in the management of dlbcl
-
8:54
stephen j. schuster, md: tisagenlecleucel promising in relapsed/refractory dlbcl
-
50:48
relapsed/refractory b-cell lymphomas in the car-t era: improving outcomes in a population at need
-
1:19
the future of car t-cell therapy in b-cell malignancies
-
1:33
management of relapse after car-t in patients with b-cell lymphoma
-
2:55
car t-cell update: what’s new in dlbcl and mm?